Objectives: The efficacy of dapagliflozin as add-on therapy to metformin has been assessed in randomized trials. However, its effectiveness has not been assessed in a US real-world setting. Methods: ...

Investigational Compound Dapagliflozin Added to Metformin Sustained Reductions in Blood Sugar Levels in Adult Patients with Type 2 Diabetes in Two-Year Study Episodes of low blood sugar were less ...

Investigational Compound Dapagliflozin with Metformin Extended-Release (XR) as Initial Combination Therapy Significantly Improved Blood Sugar Control in Previously-Untreated Adult Type 2 Diabetes ...

SAN DIEGO--(BUSINESS WIRE)-- Bristol-Myers Squibb Company (NYSE: BMY) and AstraZeneca (NYSE: AZN) today announced results from two 24-week Phase 3 clinical studies examining the investigational ...

Please provide your email address to receive an email when new articles are posted on . ORLANDO — Dapagliflozin, an investigational selective sodium-glucose cotransporter-2 inhibitor, improved HbA1c ...

As was the case in dapagliflozin monotherapy, a drug manufacturer also presented no suitable data for the therapeutic indication in its dossier on the fixed combination with metformin. Dapagliflozin ...

Amit Bansal, Managing Director, Theon Pharmaceuticals Ltd says this fixed-dose combination tablet of linagliptin, dapagliflozin, and metformin hydrochloride is a suitable option for the following ...

This medication is mainly used to treat type 2 diabetes but is also given to patients with heart failure and chronic kidney ...

This drug is commonly prescribed for type 2 diabetes, but the NHS says to seek immediate medical help for three side effects ...

Episodes of low blood sugar were less frequent in patients treated with dapagliflozin added to metformin than in patients treated with glipizide added to metformin In addition to sustained reductions ...